EP08.02-082 Treatment Patterns and Outcomes of First-line Osimertinib-treated Advanced EGFR Mutated NSCLC Patients: A Real-world StudyJ.Y. Lee, G. Liu, F.A. Shepherd et al.|Journal of Thoracic Oncology|2022Cited by 6